Kenvue Marks Independence By Extending Motrin And Tylenol Lines With Help From A Competitor

Kenvue also not standing apart from competitors concerning headwinds from foreign exchange rates, a slow start to the cough/cold season and looking ahead to FDA decision on oral phenylephrine, it reports with its third-quarter results.

• Source: Shutterstock

Kenvue Inc.’s early months as a standalone company, after Johnson & Johnson sold its controlling stake, haven’t meant it’s standing alone in the consumer health segment and isn’t working with competitors to expand its business.

Neither is Kenvue standing apart from its competitors concerning headwinds from foreign exchange rates, the firm reported 26 October with...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Earnings

Trump’s Latest Tariff Order Reheats Consumer Worries And Price Increases In Healthcare Sector

 

When consumer health and beauty firms announce results for current quarter, they likely will note trend many reported after first quarter, an uptick in revenues and volume due to consumer concern about Trump’s tariffs gambit leading to higher product prices.

Henkel: ‘Subdued’ North American Consumer Sentiment, Destocking Hampered First Half Sales

 

Henkel’s Consumer Brands division in the first half of the year declined 6.8%, reflecting ‘subdued’ consumer sentiment and destocking, though the negative trend eased up in the second quarter.

E.l.f. Expects Sales To Double On International Growth, Rhode Acquisition

 

Oakland, Calif.-based e.l.f. Beauty, Inc. says it expects white space opportunities and the Hailey Bieber rhode lifestyle beauty acquisition to more than double its business in coming years.

NIVEA’s ‘Milestone’ Launch Brings ‘Breakthrough’ Anti-Aging Tech To Masses

 

Beiersdorf is launching NIVEA Epigenetics Rejuvenating Serum with Epicelline, the biggest launch in its history. The range will debut first in Europe, reaching 30 countries by the end of 2025.

More from Business

E.l.f. Expects Sales To Double On International Growth, Rhode Acquisition

 

Oakland, Calif.-based e.l.f. Beauty, Inc. says it expects white space opportunities and the Hailey Bieber rhode lifestyle beauty acquisition to more than double its business in coming years.

NIVEA’s ‘Milestone’ Launch Brings ‘Breakthrough’ Anti-Aging Tech To Masses

 

Beiersdorf is launching NIVEA Epigenetics Rejuvenating Serum with Epicelline, the biggest launch in its history. The range will debut first in Europe, reaching 30 countries by the end of 2025.

Aloette Beauty Referred To FTC For Failing To Participate In Self-Reg Forum Over Earnings Claims

 

Aloette Cosmetics will face the FTC for possible enforcement action after it failed to respond to multiple inquiries by the BBB National Program’s Direct Selling Self-Regulatory Council.